| Literature DB >> 29150562 |
Helen L Wu1, Roger W Wiseman2, Colette M Hughes1, Gabriela M Webb1, Shaheed A Abdulhaqq1, Benjamin N Bimber3, Katherine B Hammond1, Jason S Reed1, Lina Gao3,4, Benjamin J Burwitz1,3, Justin M Greene1, Fidel Ferrer1, Alfred W Legasse3, Michael K Axthelm3, Byung S Park3,5, Simon Brackenridge6, Nicholas J Maness7,8, Andrew J McMichael6, Louis J Picker1,3, David H O'Connor2,9, Scott G Hansen1, Jonah B Sacha10,3.
Abstract
MHC-E is a highly conserved nonclassical MHC class Ib molecule that predominantly binds and presents MHC class Ia leader sequence-derived peptides for NK cell regulation. However, MHC-E also binds pathogen-derived peptide Ags for presentation to CD8+ T cells. Given this role in adaptive immunity and its highly monomorphic nature in the human population, HLA-E is an attractive target for novel vaccine and immunotherapeutic modalities. Development of HLA-E-targeted therapies will require a physiologically relevant animal model that recapitulates HLA-E-restricted T cell biology. In this study, we investigated MHC-E immunobiology in two common nonhuman primate species, Indian-origin rhesus macaques (RM) and Mauritian-origin cynomolgus macaques (MCM). Compared to humans and MCM, RM expressed a greater number of MHC-E alleles at both the population and individual level. Despite this difference, human, RM, and MCM MHC-E molecules were expressed at similar levels across immune cell subsets, equivalently upregulated by viral pathogens, and bound and presented identical peptides to CD8+ T cells. Indeed, SIV-specific, Mamu-E-restricted CD8+ T cells from RM recognized antigenic peptides presented by all MHC-E molecules tested, including cross-species recognition of human and MCM SIV-infected CD4+ T cells. Thus, MHC-E is functionally conserved among humans, RM, and MCM, and both RM and MCM represent physiologically relevant animal models of HLA-E-restricted T cell immunobiology.Entities:
Mesh:
Substances:
Year: 2017 PMID: 29150562 PMCID: PMC5736429 DOI: 10.4049/jimmunol.1700841
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422